Ignyta Appoints Sara Zaknoen, M.D., as Chief Medical Officer

Published February 22, 2014

Ignyta Appoints Sara Zaknoen, M.D., as Chief Medical Officer

Filed under: drug treatment programs maryland

SAN DIEGO, Feb 19, 2014 (BUSINESS WIRE) — Ignyta, Inc. (otcqb:RXDX), an oncology precision medicine biotechnology company, announced today that Sara Zaknoen, M.D., has been appointed as Chief Medical Officer, assuming full-time responsibilities for …
Read more on MarketWatch

NIH Team Discovers Genetic Disorder Causing Strokes and Vascular …

Filed under: drug treatment programs maryland

“This discovery is another example of genome sequencing playing a central role in revealing the genomic basis for an important rare disease,” said Eric D. Green, M.D., Ph.D., director of the National Human Genome Research Institute (NHGRI), where the …
Read more on eNews Park Forest